Related Experiment Video
Updated: Aug 28, 2025
08:35
Hybrid Printing for the Fabrication of Smart Sensors
Published on: January 31, 2019
8.2K
Three-Dimensional Printing and Its Potential to Develop Sensors for Cancer with Improved Performance
João B M Rocha Neto1,2, Juliana Coatrini Soares3, Guilherme A Longhitano1,4,5
1Three-Dimensional Research Group, Renato Archer Information Technology Center-CTI, Campinas 13069-901, Brazil.
Biosensors
|September 23, 2022
Summary
Three-dimensional (3D) printing offers a novel approach to creating advanced biosensors for early cancer detection. This technology enables the development of precise, low-cost, and user-friendly devices for improved point-of-care diagnostics.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Analytical Chemistry
Background:
- Cancer remains a leading global cause of death, underscoring the critical need for early diagnosis.
- Current biosensor technologies for cancer biomarker detection face limitations in selectivity and sensitivity, particularly for point-of-care applications.
- Conventional 2D manufacturing processes hinder the development of highly precise and cost-effective diagnostic tools.
Purpose of the Study:
- To review the recent advancements and applications of three-dimensional (3D) printing in the development of biosensors for cancer diagnosis.
- To highlight the advantages offered by 3D printing in creating sophisticated biosensor designs.
- To address the challenges associated with the mass production of 3D-printed biosensors for clinical use.
Main Methods:
- Review of recent scientific literature on 3D printing applications in biosensor fabrication for cancer detection.
- Analysis of different 3D printing techniques and materials used for biosensor development.
- Evaluation of the performance metrics (selectivity, sensitivity, cost) of 3D-printed biosensors compared to conventional methods.
Main Results:
- Three-dimensional printing enables the fabrication of complex sensor geometries, enhancing precision and performance.
- Additive manufacturing facilitates the creation of sensitive, user-friendly, and semi-automated biosensors with controlled composition and functionality.
- Significant progress has been made in utilizing 3D printing for developing electrochemical, optical, and other biosensing platforms for cancer biomarkers.
Conclusions:
- Three-dimensional printing is a promising technology for the next generation of high-performance, low-cost biosensors for cancer diagnosis.
- The ability to precisely control sensor design and material composition through 3D printing addresses key limitations of current diagnostic methods.
- Further research and development are needed to overcome challenges in scaling up production for widespread clinical adoption.
